Page 145 - Read Online

48. Lahat N, Shapiro S, Froom P, Kristal‑Boneh E, Inspector M, Miller A. extracellular signal‑regulated kinase pathway in human vascular
Inorganic lead enhances cytokine‑induced elevation of matrix endothelial cells. Brain Res 2012;1455:19‑27.
metalloproteinase MMP‑9 expression in glial cells. J Neuroimmunol 70. Wang Q, Luo W, Zheng W, Liu Y, Xu H, Zheng G, Dai Z, Zhang W,
2002;132:123‑8. Chen Y, Chen J. Iron supplement prevents lead‑induced disruption
49. Sansar W, Ahboucha S, Gamrani H. Chronic lead intoxication affects of the blood‑brain barrier during rat development. Toxicol Appl
glial and neural systems and induces hypoactivity in adult rat. Acta Pharmacol 2007;219:33‑41.
Histochem 2011;113:601‑7. 71. Gu H, Wei X, Monnot AD, Fontanilla CV, Behl M, Farlow MR,
50. Little AR, O’Callagha JP. Astrogliosis in the adult and developing Zheng W, Du Y. Lead exposure increases levels of β‑amyloid in
CNS: is there a role for proinflammatory cytokines? Neurotoxicology the brain and CSF and inhibits LRP1 expression in APP transgenic
2001;22:607‑18. mice. Neurosci Lett 2011;490:16‑20.
51. Lindahl LS, Bird L, Legare ME, Mikeska G, Bratton GR, 72. Stewart WF, Schwartz BS, Davatzikos C, Shen D, Liu D, Wu X,
Tiffany‑Castiglioni E. Differential ability of astroglia and neuronal Todd AC, Shi W, Bassett S, Youssem D. Past adult lead exposure
cells to accumulate lead: dependence on cell type and on degree is linked to neurodegeneration measured by brain MRI. Neurology
of differentiation. Toxicol Sci 1999;50:236‑43. 2006;66:1476‑84.
52. Tiffany‑Castiglioni E, Sierra EM, Wu JN, Rowles TK. Lead toxicity 73. Liu JS, John GR, Sikora A, Lee SC, Brosnan CF. Modulation
in neuroglia. Neurotoxicology 1989;10:417‑43. of interleukin‑1beta and tumor necrosis factor alpha signaling
53. Legare ME, Barhoumi R, Hebert E, Bratton GR, Burghardt RC, by P2 purinergic receptors in human fetal astrocytes. J Neurosci
Tiffany‑Castiglioni E. Analysis of Pb2+ entry into cultured astroglia. 2000;20:5292‑9.
Toxicol Sci 1998;46:90‑100. 74. Gavillet M, Allaman I, Magistretti PJ. Modulation of astrocytic metabolic
54. Gahtan E, Overmier JB. Inflammatory pathogenesis in Alzheimer’s phenotype by proinflammatory cytokines. Glia 2008;56:975‑89.
disease: biological mechanisms and cognitive sequeli. Neurosci 75. Huber JD, Witt KA, Hom S, Egleton RD, Mark KS, Davis TP.
Biobehav Rev 1999;23:615‑33. Inflammatory pain alters blood‑brain barrier permeability and
55. Ii M, Sunamoto M, Ohnishi K, Ichimori Y. Beta‑amyloid tight junctional protein expression. Am J Physiol Heart Circ Physiol
protein‑dependent nitric oxide production from microglial cells and 2001;280:H1241‑8.
neurotoxicity. Brain Res 1996;720:93‑100. 76. O’Shea RD. Roles and regulation of glutamate transporters
56. McCann MJ, O’Callaghan JP, Martin PM, Bertram T, Streit WJ. in the central nervous system. Clin Exp Pharmacol Physiol
Differential activation of microglia and astrocytes following trimethyl 2002;29:1018‑23.
tin‑induced neurodegeneration. Neuroscience 1996;72:273‑81. 77. Biber K, Vinet J, Boddeke HW. Neuron‑microglia signaling:
57. Shao W, Zhang SZ, Tang M, Zhang XH, Zhou Z, Yin YQ, Zhou QB, chemokines as versatile messengers. J Neuroimmunol
Huang YY, Liu YJ, Wawrousek E, Chen T, Li SB, Xu M, Zhou JN, 2008;198:69‑74.
Hu G, Zhou JW. Suppression of neuroinflammation by astrocytic 78. Shih AY, Johnson DA, Wong G, Kraft AD, Jiang L, Erb H,
dopamine D2 receptors via aB‑crystallin. Nature 2013;494:90‑4. Johnson JA, Murphy TH. Coordinate regulation of glutathione
58. Hu S, Sheng WS, Ehrlich LC, Peterson PK, Chao CC. Cytokine effects biosynthesis and release by Nrf2‑expressing glia potently protects
on glutamate uptake by human astrocytes. Neuroimmunomodulation neurons from oxidative stress. J Neurosci 2003;23:3394‑406.
2000;7:153‑9. 79. Bak LK, Schousboe A, Waagepetersen HS. The glutamate/
59. Thornton P, Pinteaux E, Gibson RM, Allan SM, Rothwell NJ. GABA‑glutamine cycle: aspects of transport, neurotransmitter
Interleukin‑1‑induced neurotoxicity is mediated by glia and homeostasis and ammonia transfer. J Neurochem 2006;98:641‑53.
requires caspase activation and free radical release. J Neurochem 80. McKenna MC. The glutamate‑glutamine cycle is not stoichiometric:
2006;98:258‑66. fates of glutamate in brain. J Neurosci Res 2007;85:3347‑58.
60. Boutin H, LeFeuvre RA, Horai R, Asano M, Iwakura Y, Rothwell NJ. 81. Pun PB, Lu J, Moochhala S. Involvement of ROS in BBB
Role of IL‑1alpha and IL‑1beta in ischemic brain damage. J Neurosci dysfunction. Free Radic Res 2009;43:348‑64.
2001;21:5528‑34. 82. Trotti D, Nussberger S, Volterra A, Hediger MA. Differential
61. da Cunha A, Jefferson JA, Jackson RW, Vitkovic L. Glial cell‑specific modulation of the uptake currents by redox interconversion of
mechanisms of TGF‑beta 1 induction by IL‑1 in cerebral cortex. cysteine residues in the human neuronal glutamate transporter
J Neuroimmunol 1993;42:71‑85. EAAC1. Eur J Neurosci 1997;9:2207‑12.
62. Herrera‑Molina R, von Bernhardi R. Transforming growth factor‑beta 83. Nehru B, Kanwar SS. N‑acetylcysteine exposure on lead‑induced
1 produced by hippocampal cells modulates microglial reactivity in lipid peroxidative damage and oxidative defense system in brain
culture. Neurobiol Dis 2005;19:229‑36. regions of rats. Biol Trace Elem Res 2004;101:257‑64.
63. Cardoso FL, Brites D, Brito MA. Looking at the blood‑brain barrier: 84. Xu SZ, Shan CJ, Bullock L, Baker L, Rajanna B. Pb2+reduces
molecular anatomy and possible investigation approaches. Brain PKCs and NF‑kappaB in vitro. Cell Biol Toxicol 2006;22:189‑98.
Res Rev 2010;64:328‑63.
64. Kim JH, Byun HM, Chung EC, Chung HY, Bae ON. Loss of integrity: 85. Guo F, Lou Y, Feng N, Li G, Xie A, Huang X, Wang Y.
Exposure to lanthanum compound diminishes LPS‑induced
impairment of the blood‑brain barrier in heavy metal‑associated
ischemic stroke. Toxicol Res 2013;29:157‑64. inflammation‑associated gene expression: involvements of PKC
65. Balbuena P, Li W, Ehrich M. Assessments of tight junction proteins and NF‑kappaB signaling pathways. Biometals 2010;23:669‑80.
occludin, claudin 5 and scaffold proteins ZO1 and ZO2 in endothelial 86. Nava‑Ruíz C, Alcaraz‑Zubeldia M, Méndez‑Armenta M, Vergara P,
Díaz‑Ruìz A, Ríos C. Nitric oxide synthase immunolocalization and
cells of the rat blood‑brain barrier: cellular responses to neurotoxicants
malathion and lead acetate. Neurotoxicology 2011;32:58‑67. expression in the rat hippocampus after sub‑acute lead acetate
66. Shi LZ, Zheng W. Early lead exposure increases the leakage of exposure in rats. Exp Toxicol Pathol 2010;62:311‑6.
the blood‑cerebrospinal fluid barrier, in vitro. Hum Exp Toxicol
2007;26:159‑67.
67. I Bannon D, Portnoy ME, Olivi L, Lees PS, Culotta VC, Bressler JP. Cite this article as: Liu JT, Dong MH, Zhang JQ, Bai Y, Kuang F, Chen LW.
Uptake of lead and iron by divalent metal transporter 1 in yeast and Microglia and astroglia: the role of neuroinflammation in lead toxicity and
mammalian cells. Biochem Biophys Res Commun 2002;295:978‑84. neuronal injury in the brain. Neuroimmunol Neuroinflammation 2015;2(3):131-7.
68. Wang J, Wu J, Zhang Z. Oxidative stress in mouse brain exposed Source of Support: The National Basic Research Program (2012CB525002,
to lead. Ann Occup Hyg 2006;50:405‑9. 2011CB504103) and National Natural Science Foundation of China
69. Wang Q, Lin Y, Zhang W, Liu M, Chen Y, Chen J, Luo W. (81272346, 31371374). Conflict of Interest: No.
Lead induces dysregulation of iron regulatory protein 1 via the Received: 31-08-2014; Accepted: 20-02-2015

136 Neuroimmunol Neuroinflammation | Volume 2 | Issue 3 | July 15, 2015 Neuroimmunol Neuroinflammation | Volume 2 | Issue 3 | July 15, 2015 137